Leases

6 Months Ended

Mar. 31, 2023

11. LEASES

Leases

The Company leases office and research and development facility leases under non-cancelable operating leases for various

terms through 2030. Certain lease agreements include renewal options, rent abatement periods, and rental increases throughout the

term. As of March 31, 2023, the weighted-average remaining lease term for the Company’s operating leases was 4.6 years and the weighted-average discount rate was 3.1%.

As of March 31, 2023, the Company had operating ROU assets of $4.6 million. As of March 31, 2023, total operating lease liabilities of $5.5 million were comprised of current lease liabilities of $2.0 million and non-current lease liabilities of $3.5 million. As of September 30, 2022, the Company had operating ROU assets of $5.2 million. As of September 30, 2022, total operating lease liabilities of $6.2 million were comprised of current lease liabilities of $2.1 million and non-current lease liabilities of $4.1 million.

The Company recognized $0.5 million of operating lease costs in each of the three months ended March 31, 2023 and 2022. The Company recognized $1.1 million of operating lease costs in each of the six months ended March 31, 2023 and 2022. Operating lease costs are included within cost of revenue, selling and marketing, research and development, and general and administrative expenses, dependent upon the nature and use of the ROU asset, in the Company’s condensed consolidated statement of operations and other comprehensive income (loss).

The Company paid $1.2 million in operating cash flows for operating leases in the six months ended March 31, 2023.

Maturities of operating lease liabilities as of March 31, 2023 were as follows (amounts in thousands):


	Operating leases
2023 - remaining	$	1,108
2024	1,726
2025	638
2026	629
2027	635
2028	425
Thereafter	591
Total lease payments	5,752
Less: amount representing interest	(242)
Present value of future lease payments	$	5,510